Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.01, 2.01, 7.01, 9.01 · 8-K

Ingevity Corporation

NGVTNYSEEQUITYCurrent

Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Regulation FD Disclosure

Item Entry 1.01. Into a Material Definitive Agreement Amendment to Asset Purchase Agreement In connection with the Closing, on January 1, 2026, the Parties entered into the Amendment, which, among other things, modified the scope of assets being transferred pursuant to the Original Purchase Agreement by excluding non-lignin dispersant products sold to existing customers for agricultural chemical applications.…

Filed Jan 5, 2026Accepted Jan 5, 2026, 6:39 AM ESTCIK 1653477Accession 0001493152-26-000248
Share

Company context

Current securities

Recent company filings

  1. 10-Q filingNov 5, 2026
  2. Results of Operations and Financial ConditionNov 4, 2026
  3. 4 filingOct 2, 2026
  4. 4 filingAug 14, 2026
  5. 10-Q filingJul 30, 2026

Registered securities in this filing

INGEVITY CORPORATION · 8-K · Filed 2026-01-05

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock ($0.01 par value)

Symbol
NGVT
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: AsOf2026-01-01

Dimensions: Not supplied

Accession 000149315226000248 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.01, 2.01, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item Entry 1.01. Into a Material Definitive Agreement Amendment to Asset Purchase Agreement In connection with the Closing, on January 1, 2026, the Parties entered into the Amendment, which, among other things, modified the scope of assets being transferred pursuant to the Original Purchase Agreement by excluding non-lignin dispersant products sold to existing customers for agricultural chemical applications. Except to the extent specifically amended in, or supplemented by, the Amendment, the Purchase Agreement, which was filed as Exhibit 2.1 to the Previous Form 8-K, remains unchanged and in full force and effect. The foregoing summary of the Amendment does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Amendment, which is filed as Exhibit 2.2 hereto and incorporated herein by reference.
Item 2.01Item 2.01 - Completion of Acquisition
Item Completion 2.01. of Acquisition or Disposition of Assets The information provided under the Introductory Note and Item 1.01 in this Current Report on Form 8-K are incorporated by reference into this Item 2.01. In accordance with the Purchase Agreement, on January 1, 2026, Buyer purchased substantially all of the assets and assumed and acquired certain of the rights and liabilities of Ingevity or its applicable affiliates that related to or are used in connection with (a) Ingevity’s industrial specialties product line (other than certain businesses and products more fully described in the Purchase Agreement) and (b) Ingevity’s North Charleston, South Carolina crude tall oil refinery and Ingevity’s and its affiliates’ operations thereof. The foregoing description of the Purchase Agreement and the disposition by Ingevity thereunder does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Purchase Agreement filed as Exhibit 2.1 to the Previous Form 8-K and the full text of the Amendment filed as Exhibit 2.2 hereto, each of which are incorporated herein by reference.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item Regulation 7.01. FD Disclosure On January 5, 2026, Ingevity issued a press release announcing that it had completed the Transaction. A copy of the press release is filed as Exhibit 99.1 hereto and incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htm

Exhibit 99.1 Ingevity Corporation 4920 O’Hear Avenue Suite 400 North Charleston, S.C. 29405 USA www.ingevity.com News Contact: Caroline Monahan 843-740-2068 caroline.monahan@ingevity.com Investors: John E. Nypaver, Jr. 843-740-2002 investors@ingevity.com Ingevity announces successful completion of sale of North Charleston crude tall oil refinery and majority of Industrial Specialties product line Transaction reduces portfolio volatility, strengthens Ingevity’s margin and cash flow profile and enhances strategic flexibility NORTH CHARLESTON, SC, Jan. 5, 2026 - Ingevity Corporation (NYSE: NGVT) today announced the completion of the previously disclosed sale of its North Charleston Crude Tall Oil (CTO) refinery assets and the majority of its Performance Chemicals Industrial Specialties product line to Mainstream Pine Products, LLC (Mainstream). Per the terms of the agreement, the all-cash transaction includes $110 million at closing plus pote…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.